Royal Bank of Canada’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $31.7M | Buy |
|
|||||
|
2024
Q4 | $13.7M | Buy |
|
|||||
|
2024
Q3 | $9.96M | Buy |
|
|||||
|
2024
Q2 | $2.78M | Buy |
|
|||||
|
2024
Q1 | $2.63M | Sell |
|
|||||
|
2023
Q4 | $4.83M | Buy |
|
|||||
|
2023
Q3 | $2.55M | Sell |
|
|||||
|
2023
Q2 | $4.13M | Buy |
|
|||||
|
2023
Q1 | $2.96M | Sell |
|
|||||
|
2022
Q4 | $2.95M | Buy |
|
|||||
|
2022
Q3 | $2.04M | Buy |
|
|||||
|
2022
Q2 | $1.08M | Sell |
|
|||||
|
2022
Q1 | $1.37M | Sell |
|
|||||
|
2021
Q4 | $1.91M | Buy |
|
|||||
|
2021
Q3 | $1.11M | Buy |
|
|||||
|
2021
Q2 | $793K | Buy |
|
|||||
|
2021
Q1 | $472K | Sell |
|
|||||
|
2020
Q4 | $872K | Sell |
|
|||||
|
2020
Q3 | $719K | Buy |
|
|||||
|
2020
Q2 | $125K | Sell |
|
|||||
|
2020
Q1 | $111K | Sell |
|
|||||
|
2019
Q4 | $275K | Sell |
|
|||||
|
2019
Q3 | $147K | Sell |
|
|||||
|
2019
Q2 | $274K | Sell |
|
|||||
|
2019
Q1 | $426K | Buy |
|
|||||
|
2018
Q4 | $343K | Sell |
|
|||||
|
2018
Q3 | $677K | Buy |
|
|||||
|
2018
Q2 | $72K | Buy |
|
|||||
|
2018
Q1 | $79K | Sell |
|
|||||
|
2017
Q4 | $70K | Sell |
|
|||||
|
2017
Q3 | $116K | Buy |
|
|||||
|
2017
Q2 | $57K | Sell |
|
|||||
|
2017
Q1 | $103K | Sell |
|
|||||
|
2016
Q4 | $114K | Buy |
|
|||||
|
2016
Q3 | $42K | Buy |
|
|||||
|
2016
Q2 | $104K | Buy |
|
|||||
|
2016
Q1 | $61K | Buy |
|
|||||
|
2015
Q4 | $115K | Buy |
|
|||||
|
2015
Q3 | $82K | Sell |
|
|||||
|
2015
Q2 | $129K | Buy |
|
|||||
|
2015
Q1 | $9K | Buy |
|